New European Pharmacopoeia Reflects Regulatory And Scientific Progress
Executive Summary
The European Pharmacopoeia, which has been updated to reflect regulatory and scientific advances, contains 114 new monographs including substances of “high therapeutic interest.” Holders of CEPs have been advised to update their certificates in line with the new monographs.
You may also be interested in...
Petra Dörr: EDQM Appoints First New Director In 14 Years
The European Directorate for the Quality of Medicines & HealthCare, which is responsible for the European Pharmacopoeia, is to be led by former Swissmedic regulator and current World Health Organization executive Petra Dörr.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.